A Phase III Open-Label Multi-Center Study of the Pharmacokinetics, Safety, and Efficacy of Coagadex in the Treatment of Adults With Acquired Factor X Deficiency Associated With Light Chain Amyloidosis
Latest Information Update: 16 May 2025
At a glance
- Drugs Factor X (Primary)
- Indications Blood coagulation disorders
- Focus Therapeutic Use
- Sponsors Kedrion
Most Recent Events
- 16 May 2025 New trial record